ADENOSINE RECEPTOR A2A

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 11:42:57 UTC 2023` Edited by `admin` on `Sat Dec 16 11:42:57 UTC 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	Y154T023U0
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ADENOSINE RECEPTOR A2A

Common Name

English

A2A

Common Name

English

ADORA2

Common Name

English

ADENOSINE A2A RECEPTOR

Common Name

English

Code System Code Type Description

FDA UNII

Y154T023U0

Created by admin on Sat Dec 16 11:43:00 UTC 2023 , Edited by admin on Sat Dec 16 11:43:00 UTC 2023

PRIMARY

PHAROS

P29274

Created by admin on Sat Dec 16 11:43:00 UTC 2023 , Edited by admin on Sat Dec 16 11:43:00 UTC 2023

PRIMARY

UNIPROT

P29274

Created by admin on Sat Dec 16 11:43:00 UTC 2023 , Edited by admin on Sat Dec 16 11:43:00 UTC 2023

PRIMARY

From	To
1_71	1_159
1_74	1_146
1_77	1_166
1_259	1_262

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_154

Related Record Type Details


					T5HB1E831H

CGS-21680

AGONIST -> TARGET

Interaction Type:

BINDING

Qualification:

Amount:


					Y5A5D5E2AQ

CGS-15943

INHIBITOR -> TARGET


					BTS1Y6777M

APADENOSON

AGONIST -> TARGET

Amount:


					9PTP4FOI9E

8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					LJA4M1L5LG

BINODENOSON

AGONIST -> TARGET

Amount:


					0I55128JYK

THEOPHYLLINE ANHYDROUS

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					NB2H3PD83X

FK-3453

INHIBITOR -> TARGET


					HZ03U10J2Z

EVODENOSON

AGONIST -> TARGET

Amount:


					L9RDR3F7GU

INUPADENANT, (±)-

INHIBITOR -> TARGET


					950O97NUPO

PRELADENANT

INHIBITOR -> TARGET

Comments:

Approximately 1000-fold more selective over other ARs.

Qualification:

Amount:


					8KFO2187CP

CIFORADENANT

INHIBITOR -> TARGET

Qualification:

Amount:


					4309023MAH

SCH-58261

INHIBITOR -> TARGET

Comments:

Highly selective over hA2B Ki = 1110 nM.

Qualification:

Amount:


					Z499CLJ023

REVERSINE

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST

Qualification:

IC50

Amount:


					K34EA3ZC92

TMSX C-11

RADIOLIGAND->TARGET

Amount:


					770140J08A

IMARADENANT

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST

Qualification:

Amount:


					3WC8SJ5ZLJ

NECA

AGONIST -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					96WL843U8D

2-METHOXYIDAZOXAN 6,7-H-3

RADIOLIGAND->TARGET

Interaction Type:

BINDING

Qualification:

Amount:


					SVJ8KG89JE

TAMINADENANT HYDROXY METABOLITE

INHIBITOR -> TARGET

Qualification:

Amount:


					Q4H682B2VZ

GR-79236

WEAK AGONIST->OFF TARGET

Comments:

Rat brain receptor

Interaction Type:

BINDING

Qualification:

Amount:


					I89Y79062L

ETAZOLATE

INHIBITOR -> TARGET


					DY6W3NQA36

PBF-999

INHIBITOR -> TARGET

Amount:


					8GG6N4T6DD

NECA H3

RADIOLIGAND->TARGET

Qualification:

Amount:


					E27LB7P0ET

2-METHOXYIDAZOXAN

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					FF2012ZV92

Sipagladenant

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Y29E2DV2VU

ATL-444

INHIBITOR -> TARGET

Amount:


					D9K857J81I

TOZADENANT

INHIBITOR -> TARGET

Comments:

selective antagonsist

Qualification:

Amount:


					263T0E9RR9

DYPHYLLINE

INHIBITOR -> TARGET


					2Y49VWD90Q

YOHIMBINE

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					84I5UEP321

TAMINADENANT

INHIBITOR -> TARGET

Comments:

Showed high selectivity over other adenosine receptors.

Qualification:

Amount:


					3G6A5W338E

CAFFEINE

WEAK INHIBITOR->TARGET

Comments:

Nonselective adenosine receptor antagonist. May be responsible for pain relief.

Qualification:

Amount:


					8L3OAJ1R5A

UK-432097

AGONIST -> TARGET

Amount:


					W0ZE0NT8IF

ETRUMADENANT

INHIBITOR -> TARGET

Comments:

Kb actually

Qualification:

Amount:


					P94ZFU28XH

CGS-21680 H-3

RADIOLIGAND->TARGET

Qualification:

Amount:


					7AXV542LZ4

REGADENOSON ANHYDROUS

AGONIST -> TARGET

Amount:


					FF2012ZV92

Sipagladenant

INVERSE AGONIST->TARGET

Qualification:

EC50

Amount:


					NTK8WWM73W

ST-1535

INHIBITOR -> TARGET

Amount:


					3G6A5W338E

CAFFEINE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					LDR3USH1NJ

VIPADENANT

INHIBITOR -> TARGET


					5NIC36BO71

ZM-241385

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST

Qualification:

Amount:


					2OT4KAG5JL

SONEDENOSON

AGONIST -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL